iDICss robustly predicts melanoma immunotherapy response by synergizing genomic and transcriptomic knowledge via independent component analysis

Clin Transl Med. 2025 Jan;15(1):e70183. doi: 10.1002/ctm2.70183.

Authors

Jiayue Qiu¹, Nana Jin², Lixin Cheng², Chen Huang¹

Affiliations

¹ Dr. Nesher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR, China.
² Health Data Science Center, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.

No abstract available

Grants and funding